2-(benzyloxy)-7,12-dihydropyrido[3,2-b:5,4-b']diindole

ID: ALA5289687

Max Phase: Preclinical

Molecular Formula: C24H17N3O

Molecular Weight: 363.42

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(COc2ccc3c(c2)[nH]c2c3ncc3[nH]c4ccccc4c32)cc1

Standard InChI:  InChI=1S/C24H17N3O/c1-2-6-15(7-3-1)14-28-16-10-11-18-20(12-16)27-24-22-17-8-4-5-9-19(17)26-21(22)13-25-23(18)24/h1-13,26-27H,14H2

Standard InChI Key:  LRKGLCIMHZWMMK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 33  0  0  0  0  0  0  0  0999 V2000
   -2.1178   -2.9240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4032   -2.5118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6914   -2.9237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6914   -3.7489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4015   -4.1607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1178   -3.7527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0914   -3.9949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5835   -3.3271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1127   -2.6734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4434   -1.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2448   -1.8581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7157   -2.5118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850   -3.2462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4156   -1.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7198   -0.6652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1189   -1.2018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7237    0.1377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    0.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1163    0.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1178   -0.6693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    1.3433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7255    1.7461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7255    2.5516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0279    2.9546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0287    3.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7265    4.1607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4214    3.7612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4261    2.9561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  9  8  2  0
  3  9  1  0
  9 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
 11 14  1  0
 15 14  2  0
 10 16  1  0
 16 15  1  0
 15 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 14 20  1  0
 18 21  1  0
 21 22  1  0
 22 23  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 23 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5289687

    ---

Associated Targets(Human)

GABRA1 Tclin GABA-A receptor; anion channel (986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.42Molecular Weight (Monoisotopic): 363.1372AlogP: 5.93#Rotatable Bonds: 3
Polar Surface Area: 53.70Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.31CX Basic pKa: 3.58CX LogP: 4.94CX LogD: 4.94
Aromatic Rings: 6Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: -0.08

References

1. Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R..  (2021)  β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.,  64  (3.0): [PMID:33528252] [10.1021/acs.jmedchem.0c01887]

Source